Successful hormonal treatment of pulmonary parenchymal endometriosis

article OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This case report describes the successful hormonal treatment of a rare instance of pulmonary parenchymal endometriosis presenting as catamenial hemoptysis using a GnRH analogue followed by danazol.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endornetriosis usually remains localized to the peritoneal cavity and intrathoracic endometriosis, in both its pleural and parenchymal forms, is very rare [l]. It can manifest as catamenial pneumothorax, catamenial hemoptysis, or an asymptomatic pulmonary nodule. The catamenial occurrence of symptoms is highly typical and is the most important diagnostic indicator. There is limited information available regarding the management of this disorder. We report a woman with catamenial hemoptysis which was diagnosed clinically and treated successfully with a gonadotropin-releasing hormone analogue followed by danazol. A 31-year-old Japanese woman (gravida 0, para 0) was admitted to our hospital after three episodes of hemoptysis over 3 months, all at the

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents, Hormonal Buserelin Danazol Endometriosis Estrogen Antagonists Lung Diseases Adult Antineoplastic Agents, Hormonal Buserelin Danazol Endometriosis Endometriosis Estrogen Antagonists Female Hemoptysis Hemoptysis Humans Lung Diseases Lung Diseases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (3)

Cited by (6)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:46.468712+00:00
License: CC0 · commercial use OK